Literature DB >> 7895176

Bone mineral density, sex steroids, and mineral metabolism in premenopausal smokers.

N Ortego-Centeno1, M Muñoz-Torres, J Hernandez-Quero, A Jurado-Duce, J de la Higuera Torres-Puchol.   

Abstract

Smoking is related to decreased bone mass and increased risk of osteoporotic fractures. However, the harmful effects of smoking on bone have not been well characterized. The purpose of this study was to assess the repercussions of smoking on bone mass in premenopausal women, and the relationship between these effects and parameters of mineral metabolism and hormone profile. We measured bone mineral density (BMD) in 101 premenopausal women (47 smokers, 54 nonsmokers) with dual-energy X-ray absorptiometry (DeXA) of the proximal femur and lumbar spine. In a subgroup of the sample (16 smokers, 15 nonsmokers) we measured biochemical indicators of mineral metabolism and hormone profile. BMD in the femoral neck, Ward's triangle, and the intertrochanter region was significantly lower in smokers (P < 0.05) than in nonsmokers. Concentrations of sex hormone-binding globulin were higher, and free testosterone index (FTI) was lower (P < 0.05) in smokers. We found no significant differences between the groups in parameters of mineral metabolism. Concentrations of dehydroepiandrosterone sulfate and free testosterone index were directly correlated with values of BMD in different sites. Our findings show that smoking by premenopausal women is associated with decreased BMD and characteristic changes in the hormone profile.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7895176     DOI: 10.1007/bf00298551

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  34 in total

1.  Cigarette smoking, steroid hormones, and bone mineral density in young women.

Authors:  M Daniel; A D Martin; D T Drinkwater
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  A case-control study of cancer of endometrium in Athens.

Authors:  Y Koumantaki; A Tzonou; E Koumantakis; E Kaklamani; D Aravantinos; D Trichopoulos
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

3.  Osteoporosis of the slender smoker revisited by epidemiologic approach.

Authors:  G F Jensen
Journal:  Eur J Clin Invest       Date:  1986-06       Impact factor: 4.686

4.  Osteoporosis and smoking.

Authors:  H W Daniell
Journal:  JAMA       Date:  1972-07-31       Impact factor: 56.272

5.  The epidemiology of benign breast disease.

Authors:  V L Ernster
Journal:  Epidemiol Rev       Date:  1981       Impact factor: 6.222

6.  Bone mineral density in hyperandrogenic amenorrhoea.

Authors:  J Prezelj; A Kocijancic
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

7.  Cigarette smoking and benign breast disease.

Authors:  G S Berkowitz; P F Canny; V A Vivolsi; M J Merino; T Z O'Connor; J L Kelsey
Journal:  J Epidemiol Community Health       Date:  1985-12       Impact factor: 3.710

8.  Effects of nicotine on cellular function in UMR 106-01 osteoblast-like cells.

Authors:  M A Fang; P J Frost; A Iida-Klein; T J Hahn
Journal:  Bone       Date:  1991       Impact factor: 4.398

9.  Effect of weight, smoking, and estrogen use on the risk of hip and forearm fractures in postmenopausal women.

Authors:  A R Williams; N S Weiss; C L Ure; J Ballard; J R Daling
Journal:  Obstet Gynecol       Date:  1982-12       Impact factor: 7.661

10.  Validity of the calculation of non-sex hormone-binding globulin-bound estradiol from total testosterone, total estradiol and sex hormone-binding globulin concentrations in human serum.

Authors:  A Belgorosky; M E Escobar; M A Rivarola
Journal:  J Steroid Biochem       Date:  1987-10       Impact factor: 4.292

View more
  10 in total

1.  Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women.

Authors:  Kathleen E Bainbridge; MaryFran Sowers; Xihong Lin; Sioban D Harlow
Journal:  Osteoporos Int       Date:  2004-01-22       Impact factor: 4.507

2.  Dose-related effect of urinary cotinine levels on bone mineral density among Korean females.

Authors:  J-P Myong; H-R Kim; S E Choi; J-W Koo
Journal:  Osteoporos Int       Date:  2012-08-14       Impact factor: 4.507

3.  Smoking among premenopausal women is associated with increased risk of low bone status: the JPOS Study.

Authors:  Junko Tamaki; Masayuki Iki; Yuho Sato; Etsuko Kajita; Sadanobu Kagamimori; Yoshiko Kagawa; Hideo Yoneshima
Journal:  J Bone Miner Metab       Date:  2009-10-15       Impact factor: 2.626

4.  Cigarette smoking, sex hormones and bone density in women.

Authors:  M R Law; R Cheng; A K Hackshaw; S Allaway; A K Hale
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

5.  A meta-analysis of the effects of cigarette smoking on bone mineral density.

Authors:  K D Ward; R C Klesges
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

6.  Associations between body morphology and bone mineral density in premenopausal women.

Authors:  P Orozco; J M Nolla
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

7.  Salivary testosterone is associated with higher lumbar bone mass in premenopausal healthy women with normal levels of serum testosterone.

Authors:  P Orozco; M A Navarro; J M Nolla
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

8.  Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.

Authors:  M Muñoz-Torres; E Jódar; F Escobar-Jiménez; P J López-Ibarra; J D Luna
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

9.  Determinants of plasma parathyroid hormone levels in young women.

Authors:  Julie M Paik; Gary C Curhan; John P Forman; Eric N Taylor
Journal:  Calcif Tissue Int       Date:  2010-07-15       Impact factor: 4.333

10.  Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?

Authors:  Shaymaa Abdalwahed Abdulameer; Syed Azhar Syed Sulaiman; Mohamed Azmi Ahmad Hassali; Karuppiah Subramaniam; Mohanad Naji Sahib
Journal:  Patient Prefer Adherence       Date:  2012-06-11       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.